Keap1-Nrf2-IN-19
Keap1-Nrf2-IN-19 (compound 33) is an oral active Keap1-Nrf2 protein–protein interaction (PPI) inhibitor with the Kd value of 0.0014 μM. Keap1-Nrf2-IN-19 exhibits less than 50% inhibition at 30 μM against hERG and 10 μM against CYPs[1].
Product Specifications
UNSPSC
12352005
Target
Keap1-Nrf2
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/keap1-nrf2-in-19.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](C(O)=O)[C@@H](C1=CC(OCC2(C#N)CC2)=C(C=C1)C)NC([C@H](C3=CC=C(C=C3)C)F)=O
Molecular Formula
C25H27FN2O4
Molecular Weight
438.49
References & Citations
[1]Otake K, et al. Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors. J Med Chem. 2024 Feb 26.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880264-100 1x 100 µL
Human Kappa Light Chain (KLC264), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC431221-100 1x 100 µL
Cytokeratin 8/18 (B22.1 + B23.1), CF543 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 